"I’m optimistic that over the next 5-10 years with our unique Leaps approach, we will be able to make a significant contribution to this world in the areas of health and agriculture."
Passionate about transforming life science breakthroughs into successful, impactful companies
Optimistic about the bio revolution and disruptive tech that could restore patient health
Firm believer that capital can and must make the world a better place, creating tangible benefits for people and the planet
Hiking, skiing, swimming… Almost any activity in the great outdoors, best enjoyed with family
Juergen Eckhardt is EVP and Head of Leaps by Bayer, the impact investment arm, and Head of Business Development & Licensing (BDL) for the Pharmaceuticals division. He is a medical doctor and venture investor in healthcare, biotech, and agriculture with more than 20 years of experience. He is a strong believer that scientific breakthroughs can help us overcome some of humanity’s biggest challenges, including to cure and prevent chronic disease and to feed an ever-growing world population in a sustainable way – in short: science for a better life. He holds an MD from the University of Basel, Switzerland, and an MBA from INSEAD in Fontainebleau, France.